Welcome to our dedicated page for Aquabounty Technologies SEC filings (Ticker: AQB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Want to know how AquaBounty’s land-based salmon really performs? Investors comb through every 10-K and 10-Q for production costs, yield data, and genetic licensing details. This page pulls every disclosure together, so AquaBounty SEC filings explained simply is more than a promise—it’s a shortcut.
Our platform streams each document from EDGAR the minute it posts, then our AI distills the essentials. Use it for:
- AquaBounty quarterly earnings report 10-Q filing side-by-side with prior quarters.
- Real-time alerts on AquaBounty Form 4 insider transactions real-time to spot buying or selling trends.
- AquaBounty 8-K material events explained in plain English within minutes of release.
The AI layer highlights metrics that matter—feed conversion ratios, RAS construction budgets, or new GMO regulations—so you don’t have to wade through 200 pages. Whether you’re looking for an AquaBounty annual report 10-K simplified overview or detailed AquaBounty proxy statement executive compensation, everything is searchable and linked.
Need deeper context? Our dashboards connect AquaBounty insider trading Form 4 transactions with price moves, deliver concise AquaBounty earnings report filing analysis, and answer natural questions like “How does gene-editing affect margins?”—all while understanding AquaBounty SEC documents with AI.
No more manual downloads. Follow AquaBounty executive stock transactions Form 4, cross-reference footnotes, and receive summaries you can read over coffee. Complex aquaculture disclosures become actionable insights the moment they hit EDGAR.
AquaBounty Technologies entered into Note Purchase Agreements for unsecured, nonconvertible Senior Notes, raising $4,000,000 at 18% interest with a scheduled maturity of 18 months. Principal and interest are due at maturity, with restrictive covenants and events of default that include non‑payment, covenant breaches, insolvency, unauthorized board changes, Nasdaq compliance failures, delayed SEC filings, and certain financial restatements. Proceeds will be used for general corporate purposes, working capital, operational funding, and repayment of certain debts.
The financing triggered board changes: Christine T. St.Clare and Gail Sharps Myers resigned, and Graydon Bensler and Braeden Lichti were appointed as independent directors. Additional conditional resignations by Sylvia Wulf and Rick Sterling could, upon specified triggers, allow the Investors to designate a Board majority, constituting a potential change in control. The company engaged Univest Securities as placement agent for a 7.0% fee on gross proceeds and up to $125,000 in expenses.
AquaBounty Technologies (AQB) filed its Q3 2025 10‑Q, reporting a smaller net loss as it winds down operations and focuses on its Ohio Farm Site. Net loss was $1.38 million for the quarter, including a $69 thousand non‑cash impairment. Loss from continuing operations was $1.48 million, partially offset by $0.10 million income from discontinued operations.
Cash and cash equivalents were $951 thousand as of September 30, 2025, against $7.91 million of current debt and $11.93 million in total current liabilities. Stockholders’ equity was $12.24 million. Year‑to‑date, the company recorded $1.29 million in non‑cash impairment, recognized $2.01 million in loan forgiveness, and generated $7.11 million of proceeds from asset sales.
The company states there is substantial doubt about its ability to continue as a going concern without additional capital. It sold its Indiana Farm (July 2024) and Canadian subsidiary (March 2025) and continues to market remaining Ohio equipment. AQB settled a vendor dispute for $550 thousand and notes an ongoing claim related to the Ohio project. AQB regained Nasdaq minimum bid compliance on September 15, 2025. Common shares outstanding were 3,877,695 as of October 28, 2025.
AquaBounty Technologies (AQB) reported that it furnished a press release covering financial results and corporate updates for the quarter ended September 30, 2025. The press release is attached as Exhibit 99.1.
The information was furnished under Item 2.02 of Form 8-K and is not deemed “filed” under Section 18 of the Exchange Act, nor incorporated by reference except as expressly set forth.
Overview: AquaBounty Technologies, Inc. (AQB) Form 10-Q for the quarter ended June 30, 2025 reports total assets $26,650,968, total liabilities $13,037,043, stockholders' equity $13,613,925 and cash $729,569 as of June 30, 2025. The company recorded a net loss of $3,373,037 for the three months ended June 30, 2025 (six months: $2,971,902); weighted average shares outstanding ~3.87M.
Material items: the company sold its Indiana Farm (July 2024) and its Canadian subsidiary including broodstock farms and Corporate IP (March 2025), recognized $1.2M of continuing-operations impairment in 2025 (prior 2024 impairments ~$101.9M), received $2.008M loan forgiveness, converted $7.386M of accounts payable into a secured Vendor Note, and recorded $8.506M total debt as of June 30, 2025. Management discloses substantial doubt about going concern due to limited liquidity. A Term Note amendment on July 22, 2025 cured prior default.
FAQ
What is the current stock price of Aquabounty Technologies (AQB)?
What is the market cap of Aquabounty Technologies (AQB)?
